Anna E. Lindell

Anna E. Lindell

Auto-generated profile, based on publicly available information

Anna E. Lindell

Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
ALAnna E. Lindell
Anna E. Lindell
MZMaria Zimmermann-Kogadeeva
Maria Zimmermann-Kogadeeva
KPKiran R. Patil
Kiran R. Patil

1 July 2025 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
ALAnna E. Lindell
Anna E. Lindell
AGAnne Grießhammer
Anne Grießhammer
LMLena Michaelis
Lena Michaelis
DPDimitrios Papagiannidis
Dimitrios Papagiannidis
HOHannah Ochner
Hannah Ochner
KPKiran R. Patil
Kiran R. Patil
Per- and polyfluoroalkyl substances (PFAS) are persistent pollutants that pose major environmental and health concerns. While few environmental bacteria have been reported to bind PFAS, the interaction of PFAS with human-associated gut bacteria is unclear. Here we report the bioaccumulation of PFAS by 38 gut bacterial strains ranging in concentration from nanomolar to 500 μM. Bacteroides uniformis showed notable PFAS accumulation resulting in millimolar intracellular concentrations while retaining growth. In Escherichia coli, bioaccumulation increased in the absence of the TolC efflux pump, indicating active transmembrane transport. Cryogenic focused ion beam secondary-ion mass spectrometry confirmed intracellular localization of the PFAS perfluorononanoic acid (PFNA) in E. coli. Proteomic and metabolomic analysis of PFNA-treated cells, and the mutations identified following laboratory evolution, support these findings. Finally, mice colonized with human gut bacteria showed higher PFNA levels in excreted faeces than germ-free controls or those colonized with low-bioaccumulating bacteria. Together, our findings uncover the high PFAS bioaccumulation capacity of gut bacteria.

5 February 2024 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
RBRebecca H Boston
Rebecca H Boston
RGRui Guan
Rui Guan
LKLajos Kalmar
Lajos Kalmar
SBSina Beier
Sina Beier
EHEmily C Horner
Emily C Horner
KPKiran R Patil
Kiran R Patil
Bidirectional interactions between the immune system and the gut microbiota are key contributors to various physiological functions. Immune-associated diseases such as cancer and autoimmunity, and efficacy of immunomodulatory therapies, have been linked to microbiome variation. Although COVID-19 infection has been shown to cause microbial dysbiosis, it remains understudied whether the inflammatory response associated with vaccination also impacts the microbiota. Here, we investigate the temporal impact of COVID-19 vaccination on the gut microbiome in healthy and immuno-compromised individuals; the latter included patients with primary immunodeficiency and cancer patients on immunomodulating therapies. We find that the gut microbiome remained remarkably stable post-vaccination irrespective of diverse immune status, vaccine response, and microbial composition spanned by the cohort. The stability is evident at all evaluated levels including diversity, phylum, species, and functional capacity. Our results indicate the resilience of the gut microbiome to host immune changes triggered by COVID-19 vaccination and suggest minimal, if any, impact on microbiome-mediated processes. These findings encourage vaccine acceptance, particularly when contrasted with the significant microbiome shifts observed during COVID-19 infection.

17 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAnna E. Lindell
Anna E. Lindell
AGAnne Grießhammer
Anne Grießhammer
LMLena Michaelis
Lena Michaelis
DPDimitrios Papagiannidis
Dimitrios Papagiannidis
HOHannah Ochner
Hannah Ochner
KPKiran R. Patil
Kiran R. Patil
Per- and polyfluoroalkyl Substances (PFAS) – the so-called ‘forever chemicals’ – are a major cause of environmental and health concern due to their toxicity and long-term persistence 1,2 . Yet, no efficient mechanisms for their removal have been identified. Here we report bioaccumulation of PFAS by several gut bacterial species over a wide range of concentrations from nanomolar up to 500 μM. For bioaccumulating Bacteroides uniformis, a highly prevalent species, we estimate intracellular PFAS concentration in the mM range – above that of most native metabolites. Despite this high bioaccumulation, B. uniformis cells could grow appreciably up to 250 μM perfluorononanoic acid (PFNA) exposure. Escherichia coli, which accumulated PFAS to a much lesser extent, substantially increased PFAS bioaccumulation when lacking TolC efflux pump indicating trans-membrane transport in PFAS bioaccumulation. Electron microscopy and cryogenic Focused Ion Beam-Secondary Ion Mass-spectrometry revealed distinct morphological changes and intracellular localisation of PFNA aggregates. Bioaccumulation of PFAS and transmembrane transport is also evident in proteomics, metabolomics, thermal proteome profiling, and mutations following adaptive laboratory evolution. In an in vivo context, mice colonized with human gut bacteria showed, compared to germ-free controls or those colonized with low-bioaccumulating bacteria, higher PFNA levels in excreted feces. As the gut microbiota is a critical interface between exposure and human body, our results have implications for understanding and utilizing microbial contribution to PFAS clearance.

5 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ALAnna E. Lindell
Anna E. Lindell
SKStephan Kamrad
Stephan Kamrad
IRIndra Roux
Indra Roux
SKShagun Krishna
Shagun Krishna
AGAnne Grießhammer
Anne Grießhammer
KPKiran R. Patil
Kiran R. Patil
Contamination by industrial and agricultural chemicals like pesticides are a cause of great concern due to the risk to human and environmental health. While these chemicals are often considered to have restricted activity and are labelled as such, there are concerns over a broader toxicity range. Here we report the impact of 1076 pollutants spanning diverse chemistries and indicated applications on 22 prevalent commensal gut bacteria. Our systematic investigation uncovered 588 interactions involving 168 chemicals, the majority of which were not previously reported to have antibacterial properties. Fungicides and industrial chemicals showed the largest impact with circa 30% exhibiting anti-commensal properties. We find that the sensitivity to chemical pollutants across species surprisingly correlates with that to human-targeted drugs, suggesting common susceptibility mechanisms. Using a genome-wide chemical-genetic screen, we identified membrane transport and fatty acid metabolism as major modulators of the off-target toxicity of chemicals. Mutants exhibiting chemical resistance include those defective in producing human-health-relevant metabolites like branched short-chain fatty acids, indicating that chronic exposure could lead to selection against production of beneficial metabolites. Toxicokinetic modelling suggested gut bacteria could be used as more sensitive in vitro toxicity indicators for chemicals of concern than animal models. Together, our data uncovers the off-target activity of industrial and agricultural chemicals with widespread exposure against human gut bacteria. Impact on the structure and function of the microbiota should therefore be considered in assessing chemical safety.

20 October 2022 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
SKStephan Kamrad
Stephan Kamrad
ALAnna E. Lindell
Anna E. Lindell
KPKiran R. Patil
Kiran R. Patil